Paragon Care : AGM Presentation to Shareholders, November 2017

AGM Presentation

22 November 2017 | PGC.ASX

A low-risk exposure to a rapidly growing health care company

• Company highlights

• FY17 Results Summary & Overview

• FY18 guidance and Seasonality

• Operational updates

• Vision and strategy

• Appendix:

  • Corporate Overview

Paragon is one of the premier medical equipment, device and consumables suppliers on the ASX

Platform economics, valuable distribution networks and a customer-centric business model all differentiate Paragon's service offering

Favourable macro tailwinds given the ageing population and increasing investment in health care

Well-capitalised balance sheet to pursue additional growth opportunities, with a conservative approach to debt finance and ability to use scrip for acquisitions

Highly aligned Board and management team with supportive institutional shareholder base

Shareholder returns will continue to be driven by strong growth in earnings, targeting $250 million in revenue, which supports increasing fully franked dividends to shareholders

14 value accretive acquisitions over the last 8 years have supported strong organic and inorganic growth in a highly fragmented industry

Record FY17 full year results reflect another strong year of growth with positive outlook for FY18

Revenue

$117.2m

2016: $93.4m up 25%

Net profit after tax

$10.2m

2016: $7.5m up 35%

Operating cash flow

$12.0m

2016: $7.8m up 54%

Gross profit

$46.1m

2016: $36.5m up 26%

EBITDA

$17.1m

2016: $12.1m up 41%

Earnings per share

6.2c

2016: 5.6c up 11%

Dividend per share

1.9c ff

2016: 1.4c up 36%

Cash balance

$18.6m

2016: $19.1m

Net Debt/EBITDA

1.1x

2016: 1.6x down 31%